Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-017270

SVP, CHIEF LEGAL OFFICER gave up 2,711 shares (to pay taxes)

  • SVP, CHIEF LEGAL OFFICER acquired 5,035 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-06-12 Option exercise +5,035 33,524 D
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-06-12 Shares withheld for taxes −2,711 $54.54 $147,858 30,813 D
Derivatives
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-06-12 Option exercise · Restricted Stock Units −5,035 15,102 D
Loading xslF345X05/form4-06132025_090601.xml…